Coramsine (SBP002) was an experimental cancer drug that was evaluated in preliminary clinical trials, but was abandoned by Solbec Pharmaceuticals Ltd after the results were insufficient for them to raise investment capital to continue its development.
Coramsine (SBP002) was an experimental cancer drug that was evaluated in preliminary clinical trials, but was abandoned by Solbec Pharmaceuticals Ltd...
as football, cautiously. Solbec Pharmaceuticals attempted to develop Coramsine, a 1:1 mixture of the alkaloids solamargine and solasonine extracted from...
one component of the unsuccessful experimental cancer drug candidate Coramsine. Although, solasonine has anti-infection properties it has many adverse...
one component of the unsuccessful experimental cancer drug candidate Coramsine. Solanum americanum Al Chami, L.; Mendez, R.; Chataing, B.; et al. (2003)...
Global Information